| Quando: | Back to Calendar 28 agosto 2012 (tutto il giorno) | |
|---|---|---|
| FDA panel to review Humira for reducing signs and symptoms, and achieving clinical remission in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy |
GD Star Rating
loading...
loading...
GD Star Rating
loading...
loading...















